The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
20 Park Road, Suite E
Burlingame, CA 94010 USA
888-314-8853
650-401-8739
The Jack McGovern Coats Disease Foundation (JMCDF) is a voluntary organization whose mission is to raise awareness about Coats’ disease and to raise funds to finance a cure for this debilitating disease. JMCDF was started by Jack McGovern’s parents with a promise to their son that they would not rest until there was a way to restore his vision. To this end, JMCDF raises money to support ongoing research to help Jack and others like him who wage a lifelong battle against Coats’ disease and blindness. Coats disease is a rare disorder that causes full or partial blindness. It is characterized by abnormal development of the blood vessels of the nerve-rich membrane lining the eyes (retina). These blood vessels leak and cause a buildup of lipids which can lead to blindness.
Please Note
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.
